FOXA
59
4
DHR
38
3
KEY
43
3
EXR
60
3
SHW
65
7
NKE
30
2
CVX
44
-2
HAL
60
2
SIG
49
6
XEL
69
2
AKAM
50
7
ADSK
68
2
DOV
68
7
HST
58
18
CVS
50
2
MMC
60
6
F
47
4
AIG
44
6
SYK
68
4
EMC
53
5
FOXA
59
4
DHR
38
3
KEY
43
3
EXR
60
3
SHW
65
7
NKE
30
2
CVX
44
-2
HAL
60
2
SIG
49
6
XEL
69
2
AKAM
50
7
ADSK
68
2
DOV
68
7
HST
58
18
CVS
50
2
MMC
60
6
F
47
4
AIG
44
6
SYK
68
4
EMC
53
5
Financhill
Back

Genmab AS Vs. Novo Nordisk AS Industry Stock Comparison

Sell
25

GMAB
Genmab AS

Last Price:
20.48
Seasonality Move:
3.28%
Sell
36

NVO
Novo Nordisk AS

Last Price:
102.64
Seasonality Move:
10.2%
Sell
25
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $20.47. The Score for GMAB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $102.63. The Score for NVO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $20.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $102.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.81 Sell
Relative Strength Index (14 RSI): 25.67 Sell
Chaikin Money Flow: -108040 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.29 - 23.21) Sell
Bollinger Bands (100): (22.93 - 27.51) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.94 Sell
Relative Strength Index (14 RSI): 35.3 Sell
Chaikin Money Flow: 1803215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.5 - 114.46) Sell
Bollinger Bands (100): (113.58 - 136.66) Sell

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21 Sell
20-day SMA: 22.1 Sell
50-day SMA: 23.28 Sell
200-day SMA: 26.91 Sell
8-day EMA: 21.01 Sell
20-day EMA: 21.85 Sell
50-day EMA: 23.2 Sell
200-day EMA: 26.75 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.92 Sell
20-day SMA: 107.77 Sell
50-day SMA: 116.11 Sell
200-day SMA: 127.9 Sell
8-day EMA: 104.15 Sell
20-day EMA: 107.6 Sell
50-day EMA: 114.71 Sell
200-day EMA: 120.64 Sell

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.28 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.74 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):